XML 49 R23.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stock-Based Compensation
12 Months Ended
Dec. 31, 2016
Stock-Based Compensation [Abstract]  
Stock-Based Compensation





NOTE 14 - STOCK-BASED COMPENSATION

The Company has stock-based incentive arrangements to attract and retain key personnel. In May 2015, the 2015 Equity Compensation Plan (the “2015 plan”) was approved by shareholders, which authorizes the issuance of restricted stock, stock appreciation rights, stock units and stock options to the Board of Directors and key employees. Compensation expense for service-based awards is recognized over the vesting period. Performance-based awards are recognized based on a vesting schedule and the probability of achieving goals specified at the time of the grant. The 2015 plan replaced the 2005 Equity Compensation Plan.



Stock-based compensation expense totaled $489,000,  $319,000 and $182,000 for the years ended December 31, 2016, 2015 and 2014, respectively, which consisted of grants of restricted stock and restricted stock units.



All outstanding options are fully vested and the Company has not granted any stock options since 2007. All outstanding options as of December 31, 2016 expire on July 17, 2017. The fair value of the Company’s outstanding employee stock options is estimated on the date of grant using the Black-Scholes option pricing model. The Company estimates expected market price volatility and expected term of the options based on historical data and other factors.

 

The exercise price for options granted is set at the discretion of the committee administering the Plan, but is not less than the market value of the shares as of the date of grant. An option’s maximum term is 10 years and the options vest at the discretion of the committee.  



The following tables below summarize outstanding and exercisable options at December 31, 2016 and 2015.

 





 

 

 

 

 

 

 

 



 

 

 

Weighted

 

 

 

Weighted-Average



 

 

 

Average

 

Aggregate

 

Contractual Life



 

 

 

Exercise

 

Intrinsic

 

Remaining In

(dollars in thousands, except per share amounts)

 

Shares

 

Price

 

Value

 

Years



 

 

 

 

 

 

 

 

Outstanding at January 1, 2016

 

21,211 

 

$                    27.70 

 

$                           - 

 

 

Forfeited

 

(6,130)

 

27.70 

 

 -

 

 



 

 

 

 

 

 

 

 

Outstanding at December 31, 2016

 

15,081 

 

$                    27.70 

 

$                        20 

 

0.5 



 

 

 

 

 

 

 

 

Exercisable at December 31, 2016

 

15,081 

 

$                    27.70 

 

$                        20 

 

0.5 







 

 

 

 

 

 

 

 



 

 

 

Weighted

 

 

 

Weighted-Average



 

 

 

Average

 

Aggregate

 

Contractual Life



 

 

 

Exercise

 

Intrinsic

 

Remaining In

(dollars in thousands, except per share amounts)

 

Shares

 

Price

 

Value

 

Years



 

 

 

 

 

 

 

 

Outstanding at January 1, 2015

 

87,436 

 

$                    23.60 

 

$                           - 

 

 

Expired

 

(66,225)

 

22.29 

 

 

 

 



 

 

 

 

 

 

 

 

Outstanding at December 31, 2015

 

21,211 

 

$                    27.70 

 

$                           - 

 

1.5 



 

 

 

 

 

 

 

 

Exercisable at December 31, 2015

 

21,211 

 

$                    27.70 

 

$                           - 

 

1.5 

 

Options outstanding are all currently exercisable and are summarized as follows: 





 

 

 

 

 

Shares Outstanding

 

Weighted Average

 

Weighted Average

December 31, 2016

 

Remaining Contractual Life

 

Exercise Price

15,081

 

less than 1 year

 

$

27.70



 

 

 

 

 

  

The aggregate intrinsic value of outstanding stock options and exercisable stock options was $20,000 and $0, respectively, at December 31, 2016 and 2015. Aggregate intrinsic value represents the difference between the Company’s closing stock price on the last trading day of the period, which was $29.00 and $20.96 per share at December 31, 2016 and 2015, respectively, and the exercise price multiplied by the number of options outstanding.  As of December 31, 2015, all options outstanding were anti-dilutive.



The Company has outstanding restricted stock in accordance with the Plan. As of December 31, 2016 and 2015, unrecognized stock compensation expense was $810,000 and $735,000, respectively. The following tables summarize the unvested restricted stock awards outstanding at December 31, 2016 and 2015, respectively.





 

 

 

 

 



 

Restricted Stock

 



 

 

 

 

 



 

Number of Shares

 

Weighted
 Average Grant
Date Fair Value

 



 

 

 

 

 

Nonvested at January 1, 2016

 

37,048 

 

$                    19.83 

 

Granted

 

27,403 

 

21.00 

 

Vested

 

(15,912)

 

20.09 

 

Cancelled

 

(658)

 

20.31 

 



 

 

 

 

 

Nonvested at December 31, 2016

 

47,881 

 

$                    20.41 

 

 





 

 

 

 

 



 

Restricted Stock

 



 

Number of Shares

 

Weighted
 Average Grant
Date Fair Value

 



 

 

 

 

 

Nonvested at January 1, 2015

 

29,472 

 

$                    20.83 

 

Granted

 

28,040 

 

18.63 

 

Vested

 

(20,464)

 

19.62 

 



 

 

 

 

 

Nonvested at December 31, 2015

 

37,048 

 

$                    19.83